Azenta, Inc. (AZTA)
28.62
+0.50
(+1.78%)
USD |
NASDAQ |
Feb 13, 16:00
28.62
0.00 (0.00%)
After-Hours: 16:10
Azenta Cash from Investing (Quarterly) : 36.77M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Bio-Rad Laboratories, Inc. | -43.00M |
| Bruker Corp. | -23.80M |
| Harvard Bioscience, Inc. | -0.348M |
| Phibro Animal Health Corp. | -17.18M |
| Bionano Genomics, Inc. | -4.669M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 20.85M |
| Cash from Financing (Quarterly) | -2.632M |
| Free Cash Flow | 30.93M |
| Free Cash Flow Per Share (Quarterly) | 0.3191 |
| Free Cash Flow to Equity (Quarterly) | 20.12M |
| Free Cash Flow to Firm (Quarterly) | 14.66M |
| Free Cash Flow Yield | 2.36% |